| Trial ID: | L2765 |
| Source ID: | NCT01486862
|
| Associated Drug: |
Biphasic Insulin Aspart 30
|
| Title: |
Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: biphasic insulin aspart 30
|
| Outcome Measures: |
Primary: Percentage of subjects achieving HbA1c (glycosylated haemoglobin A1c) below 7.0% | Secondary: Change in HbA1c|Total number of hypoglycemic events|Adverse events
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
26
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-10
|
| Completion Date: |
2006-07
|
| Results First Posted: |
|
| Last Update Posted: |
2023-11-02
|
| Locations: |
Pachuca, 42060, Mexico
|
| URL: |
https://clinicaltrials.gov/show/NCT01486862
|
